Document ID: chunk:federal_register_of_legislation:F2024L00218:reg:9:p2
Version: federal_register_of_legislation:F2024L00218
Segment Type: reg
Provision Reference: reg 9 (pt 2/2)
Character Range: 7077–8569

clinical onset;
(b)          where the first exposure in that period occurred at least 5 years before clinical onset; and
(c)          where the last exposure in that period occurred within the 30 years before clinical onset;
Note: being exposed to benzene as specified is defined in the Schedule 1 – Dictionary.
(9)          inhaling, ingesting or having cutaneous contact with benzene:
(a)          in an amount greater than 10 ppm-years of cumulative exposure before clinical onset;
(b)          where the first exposure occurred at least 5 years before clinical onset; and
(c)          where the last exposure occurred within the 30 years before clinical onset;
Note: ppm-years is defined in the Schedule 1 - Dictionary.
(10)      being obese for at least 5 years within the 20 years before clinical onset;
Note: being obese is defined in the Schedule 1 - Dictionary.
(11)      undergoing organ or haematopoietic stem cell transplantation, excluding corneal transplant, before clinical onset;
(12)      having one of the following autoimmune diseases before clinical onset:
(a)          autoimmune haemolytic anaemia;
(b)          giant cell arteritis;
(c)          pernicious anaemia;
(d)          polymyalgia rheumatica;
(e)          rheumatoid arthritis;
(f)           systemic lupus erythematosus;
(g)          systemic vasculitis; or
(h)          ulcerative colitis.
(13)      inability to obtain appropriate clinical management for acute myeloid leukaemia before clinical worsening.